| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |